BridgeMD
New treatment option for Speech Sound Disorder
Official title Treatment Targets in Spanish and English Bilingual Speech Intervention
ClinicalTrials.gov ID: NCT06416306
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn which speech treatment targets result in the greatest amount of speech learning in Spanish-English bilingual children with speech sound disorders. The main questions it aims to answer are: Does linguistic complexity of the treatment target increase the amount of generalized learning within the treated language?
- Phase 1: an early, usually small safety study
- Time commitment: about 6 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 8
You may be able to join if
- Participants will be regularly exposed to English for at least 3 months in one of the following ways: a) an English-speaking caregiver or sibling who...
- Caregivers will have reported concern with their child's speech development and/or reduced intelligibility on the Intelligibility in Context Scale in...
- Participants will present with 5 or more consonants or clusters missing from their phonetic inventories in each language to confirm presence of a...
You likely can't join if
- Participants receiving speech or language treatment elsewhere during their participation in this project.
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.